Company Overview of Light Sciences Oncology, Inc.
Light Sciences Oncology, Inc. engages in the development of Talaporfin sodium for the treatment of solid tumors and other indications in patients. Its Talaporfin sodium is a water-soluble drug targeted by a small, single-use, and disposable drug activator included with the drug, and is used for the treatment of patients with hepatocellular carcinoma, metastatic colorectal cancer, and benign prostatic hyperplasia/enlargement of the prostate. The company was founded in 1994 and is based in Bellevue, Washington.
12600 SE 38th Street
Bellevue, WA 98006
Founded in 1994
Key Executives for Light Sciences Oncology, Inc.
Similar Private Companies By Industry
|OcuCure Therapeutics, Inc.||United States|
|Nucryst Pharmaceuticals, Inc.||United States|
|Equi-Tox, Inc.||United States|
|Evergreen Licensing||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Light Sciences Oncology, Inc., please visit www.lsoncology.com. Company data is provided by Capital IQ. Please use this form to report any data issues.